Kezar Life Sciences
82 hedge funds and large institutions have $66M invested in Kezar Life Sciences in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
21% less funds holding
Funds holding: 104 → 82 (-22)
53% less capital invested
Capital invested by funds: $139M → $66M (-$73.4M)
79% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 28
Holders
82
Holding in Top 10
1
Calls
$866K
Puts
$709K
Top Buyers
| 1 | +$831K | |
| 2 | +$634K | |
| 3 | +$388K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$190K |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$184K |
Top Sellers
| 1 | -$710K | |
| 2 | -$531K | |
| 3 | -$424K | |
| 4 |
Jane Street
New York
|
-$416K |
| 5 |
Millennium Management
New York
|
-$403K |